Pipeline
| Indications | Phase |
|---|---|
| KIN-101 Solid Tumors 505b2 |
Clinical |
| KIN-102 Solid Tumors Partial 505b2 |
IND-enabling |
| KIN-201 Solid Tumors NCE |
Discovery |
KIN-101
Solid Tumors (505b2)
KIN-102
Solid Tumors (partial 505b2)
KIN-201
Solid Tumors (NCE)